Focused on blood-based cancer diagnostics, the company develops and commercializes liquid biopsy tests used to detect, profile, and monitor cancers using a simple blood draw. Its products, including Guardant360 for tumor genomic profiling and Shield for colorectal cancer screening, are used by oncol...
This page tracks all publicly disclosed congressional trades in Guardant Health, Inc. (GH), a company in the Healthcare sector. 2 members of Congress have disclosed trades in this stock, including 5 purchases and 6 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-11-21 | Sheldon Whitehouse | buy | $1K – $15K |
| 2022-02-28 | Donald Sternoff Beyer | sell | $1K – $15K |
| 2022-01-13 | Donald Sternoff Beyer | sell | $1K – $15K |
| 2021-12-22 | Donald Sternoff Beyer | sell | $1K – $15K |
| 2020-11-02 | Donald Sternoff Beyer | buy | $1K – $15K |
| 2020-10-22 | Donald Sternoff Beyer | buy | $1K – $15K |
| 2020-10-05 | Donald Sternoff Beyer | buy | $1K – $15K |
| 2020-07-14 | Donald Sternoff Beyer | sell | $1K – $15K |
| 2020-05-01 | Donald Sternoff Beyer | sell | $1K – $15K |
| 2020-04-27 | Donald Sternoff Beyer | sell | $1K – $15K |
| 2020-02-14 | Donald Sternoff Beyer | buy | $1K – $15K |